OJGen> Vol.3 No.1, March 2013

Department of Transplantation, UJCM, Krakow, Poland
Department of Pediatrics and Medical Genetics, Chair of Pediatrics, UJCM, Krakow, Poland
Department of Clinical Immunology, UJCM, Krakow, Poland
Department of Transplantation, UJCM, Krakow, Poland
Department of General and Molecular Biology and Genetics, Medical University of Silesia, Katowice, Poland
Department of General and Molecular Biology and Genetics, Medical University of Silesia, Katowice, Poland
Department of General and Molecular Biology and Genetics, Medical University of Silesia, Katowice, Poland
Department of General and Molecular Biology and Genetics, Medical University of Silesia, Katowice, Poland
Department of General and Molecular Biology and Genetics, Medical University of Silesia, Katowice, Poland
Department of General and Molecular Biology and Genetics, Medical University of Silesia, Katowice, Poland

 

Copyright © 2013 Marcin Majka, Magdalena Janeczko, Jolanta Goździk, Danuta Jarocha, Aleksandra Auguściak-Duma, Joanna Witecka, Marta Lesiak, Halina Koryciak-Komarska, Aleksander L. Sieroń, Jacek Józef Pietrzyk et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article

---

Majka, M. , Janeczko, M. , Goździk, J. , Jarocha, D. , Auguściak-Duma, A. , Witecka, J. , Lesiak, M. , Koryciak-Komarska, H. , Sieroń, A. and Pietrzyk, J. (2013) Cell therapy of a patient with type III osteogenesis imperfecta caused by mutation in COL1A2 gene and unstable collagen type I. Open Journal of Genetics, 3, 49-60. doi: 10.4236/ojgen.2013.31006.

 

Download citation as EndNote